Preview Mode Links will not work in preview mode

GRACEcast


Sep 16, 2012

Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell lung cancer.